Stock UniverseDerived research view · source repositories remain read-only

Generate Biomedicines, Inc. (GENB)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Qualified
Selection Score
37.60
Global Rank
790
Market Cap
1.61B
Latest Close
12.87
RS Composite
-7.17% · G#1908

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-15.88%
3M
14.81%
6M
1.74%
1Y
1.74%
3Y
1.74%
5Y
1.74%
10Y
1.74%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 1.63M · 30-day average: 680.03K · Max drawdown over stored range: -26.20%

Research Snapshot

Relative Strength vs SPX

RS Composite-7.17%
20D RS-5.93%
60D RS-7.79%
120D RSn/a
Global RS Rank1908 · 43.13% percentile
Qualified+ RS Rank707 · 43.80% percentile
Group ScopeQualified+
Primary RS Rank186 · 59.39% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank133 / 701
Primary Percentile81.17
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for GENB.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2024FY 2025
Revenue20.45931.893
Revenue Growth (YoY)55.887%
Gross Profit
Operating Income
Free Cash Flow-121.197-204.133
Free Cash Flow Per Share-3.77742-6.1906
EPS (Diluted) GAAP
EPS Growth
EPS Non-GAAP
Gross Margin100%100%
Operating Margin-962.603%-737.043%
Profit Margin-886.573%-699.103%
Free Cash Flow Margin-592.39%-640.056%
Shares Outstanding (Diluted)32.084632.9747
Shares Change (YoY)2.774%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-077.22Mn/a-64.11M-8.87%-61.45M-8.51%-1.0764.87M516.64Mn/aprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.